Home > Items where Subject is "G Health and disease > Disorder by cause > Communicable disease > Hepatitis B"

Up a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 85.

Article

O'Connell, Sarah and Lillis, Darren and Cotter, Aoife and O'Dea, Siobhan and Tuite, Helen and Fleming, Catherine and Crowley, Brendan and Fitzgerald, Ian and Dalby, Linda and Barry, Helen and Shields, Darragh and Norris, Suzanne and Plunkett, Patrick K and Bergin, Colm (2016) Opt-out panel testing for HIV, hepatitis B and hepatitis C in an urban emergency department: a pilot study. PLoS ONE , 11 , (3) , e0150546.

Garavan, Carrie and Long, Jean and Lyons, Suzi (2014) Prevalence of drug use and blood-borne viruses in Irish prisons, 2011. Drugnet Ireland , Issue 50, Summer 2014 , pp. 7-11.

Hope, VD and Eramova, I and Capurro, D and Donoghue, MC (2014) Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiology and Infection , 142 , (2) , pp. 270-286.

Ryan, H and Ryan, S (2014) Increasing incidence of hepatitis C among intravenous drug users in HSE Mid-West. NIHS Research Bulletin , 7 , (1) , p. 32.

Murphy, Niamh and Thornton, Lelia (2012) Latest HPSC reports on hepatitis B and hepatitis C notifications. Epi-Insight , 13 , (6) .

O'Kelly, Fergus Desmond and O'Kelly, CM (2012) The natural history of injecting drug use: a 25-year longitudinal study of a cohort of injecting drug users in inner city Dublin. Irish Journal of Medical Science , 181 , (4) , pp. 541-548.

Nelson, Paul K. and Mathers, Bradley M and Cowie, Benjamin and Hagan, Holly and Des Jarlais, Don C and Horyniak, Danielle and Degenhardt, Louisa (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet , 378 , (9791) , pp. 571-583.

Long, Jean (2010) Newly diagnosed drug-related viral hepatitis infections in 2008. Drugnet Ireland , Issue 33, Spring 2010 , pp. 19-20.

Murphy, Niamh and Thornton, Lelia (2008) Epidemiology of Hepatitis B in Ireland. EPI-Insight , 9 , (9) , pp. 2-3.

Long, Jean (2008) Hepatitis B surveillance: risk factor reporting in 2007. Drugnet Ireland , Issue 27, Autumn 2008 , p. 20.

Long, Jean (2007) Hepatitis surveillance in 2005. Drugnet Ireland , Issue 21, spring 2007 , p. 13.

Long, Jean (2004) Calls for an extended surveillance system for hepatitis B and hepatitis C. Drugnet Ireland , Issue 10, March 2004 , p. 10.

Long, Jean and Allwright, Shane and Barry, Joseph and Reaper-Reynolds, Sheilagh and Thornton, Lelia and Bradley, Fiona and Parry, John V (2001) Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. British Medical Journal , 323 , (7323) , pp. 1209-13.

O'Connell, T and Thornton, Lelia and O'Flanagan, D and Staines, A and Connell, J and Dooley, S and McCormack, G (2001) Oral fluid collection by post for viral antibody testing. International Journal of Epidemiology , 30 , pp. 298-301.

Cafferkey, MT and Beckett, M and Butler, KM and Cahill, I and Dooley, S and Hall, WW and Healy, CM and MacMathuna, P and McKenna, P and McMorrow, J and Philbin, M (2001) Antenatal Hepatitis B screening: is there a need for a national policy? Irish Medical Journal , 94 , (4) , 111-112, 114.

Fitzgerald, Michael and Barry, Joseph and O'Sullivan, P and Thornton, Lelia (2001) Blood-borne infections in Dublin's opiate users. Irish Journal of Medical Science , 170 , (1) , pp. 32-34.

O'Connell, T and Thornton, Lelia and O'Flanagan, D and Staines, A and Connell, J and Dooley, S and McCormack, G (2000) Prevalence of hepatitis B anti-core antibody in the Republic of Ireland. Epidemiology and Infection , 125 , (3) , pp. 701-704.

Thornton, Lelia and Barry, Joseph and Long, Jean and Allwright, Shane and Bradley, Fiona and Parry, John V (2000) Comparison between self-reported hepatitis B, hepatitis C, and HIV antibody status and oral fluid assay results in Irish prisoners. Communicable Disease and Public Health , 3 , (4) , pp. 253-255.

Allwright, Shane and Bradley, Fiona and Long, Jean and Barry, Joseph and Thornton, Lelia and Parry, John V (2000) Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. British Medical Journal , 321 , (7253) , pp. 78-82.

Shattock, AG and Jones, L and O'Mahony, Mary and Hillary, I (1989) Changes in incidence of hepatitis B in Ireland from 1970-1987. Irish Journal of Medical Science , 158 , (8) , pp. 210-214.

Shattock, Alan G and Irwin, Fiona M and Morgan, Bridget M and Hillary, Irene B and Kelly, Michael G and Fielding, JF and Kelly, Deirdre A and Weir, Donald G (1985) Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitus D virus infections. British Medical Journal , 290 , (6479) , pp. 1377-1380.

Shattock, AG and Morgan, Bridget M (1984) Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta,using serum as the delta antigen source. Journal of Medical Virology , 13 , (1) , pp. 73-82.

Shattock, AG and Morgan, Bridget M and Pautherer, John and Inglis, JM and Fielding, JF and Kelly, Michael G (1983) High incidence of delta antigen in serum. The Lancet , 2 , (8341) , pp. 104-105.

Kelly, DA and Carrol, D and Shattock, AG and O'Connor, E and Weir, DG (1983) A secondary outbreak of hepatitis B among contacts of drug-abusers in Dublin. Irish Medical Journal , 76 , (4) , pp. 205-208.

Shattock, AG and Fielding, JF (1983) Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. British Medical Journal , 286 , (6373) , pp. 1279-1280.

Shattock, AG and Fielding, JF and Arthurs, Yvonne and Doyle, GD and Kelly, Michael G (1982) Delta infection without increase in severity of hepatitis. The Lancet , 2 , (8310) , p. 1286.

Kelly, Michael G and Fielding, JF and Arthurs, Yvonne (1982) Epidemic hepatitis B with delta-antigenaemia among Dublin drug-abusers. Irish Journal of Medical Science , 151 , (11) , pp. 334-338.

Fielding, JF and Arthurs, Yvonne and Doyle, GD (1982) Sulphasalazine treatment in hepatitis B virus (HBV) associated chronic active hepatitis (CAH)- a pilot study. Irish Medical Journal , 75 , (3) , pp. 91-92.

News

[EMCDDA] EMCDDA and ECDC join forces to address the challenge of hepatitis. (13 Jun 2017)

[rte.ie] St James's to begin routine HIV, hepatitis testing of emergency department patients. (28 Jul 2015)

Health Service Executive. World hepatitis day. (28 Jul 2015)

[UNODC] UNODC Executive Director calls for prevention, fair access to treatment on World Hepatitis Day. (28 Jul 2013)

World Health Organization. WHO urges governments to act on hepatitis threat. (24 Jul 2013)

Report

World Health Organization. (2017) Global hepatitis report 2017. Geneva: World Health Organization.

Health Protection Surveillance Centre. (2016) Report on Hepatitis B notifications Quarters 1 & 2 2016. Dublin: Health Protection Surveillance Centre.

The Rotunda Hospital. (2016) Rotunda Hospital. Clinical report 2015. Dublin: The Rotunda Hospital.

The Rotunda Hospital. (2015) Rotunda Hospital. Clinical report 2014. Dublin: The Rotunda Hospital.

Drummond, Anne and Codd, Mary and Donnelly, N and McCausland, D and Mehegan, J and Daly, L and Kelleher, Cecily (2014) Study on the prevalence of drug use,including intravenous drug use, and blood-borne viruses among the Irish prisoner population. Dublin: National Advisory Committee on Drugs and Alcohol.

Drummond, Anne and Codd, Mary (2014) Drugs and health in Irish prisons 2011. A report for prisoners. National Advisory Committee on Drugs and Alcohol.

Health Protection Surveillance Centre. (2014) Health Protection Surveillance Centre annual report 2013. Dublin: Health Protection Surveillance Centre.

Blachier, Martin and Leleu, Henri and Peck-Radosavljevic, Markus and Valla, Dominique-Charles and Roudot-Thoraval, Francois (2013) The burden of liver disease in Europe. A review of available epidemiological data. Geneva: European Association for the Study of the Liver.

Health Protection Surveillance Centre. (2013) Health Protection Surveillance Centre annual report 2011. Dublin: Health Protection Surveillance Centre.

O'Heaire, Gary (2013) Cracking on: a harm reduction report. Dublin: The Bawnogue Youth and Family Support Group.

Health Protection Surveillance Centre. (2013) Report on Hepatitis B notifications 2013. Dublin: Health Protection Surveillance Centre.

World Health Organization. (2013) Global policy report on the prevention and control of viral hepatitis in WHO member states. Geneva: World Health Organization.

European Centre for Disease Prevention and. (2013) Hepatitis B and C surveillance in Europe 2006-2011. Stockholm: ECDC.

The Rotunda Hospital. (2013) Rotunda hospital. Clinical report 2012. Dublin: The Rotunda Hospital.

Gesundheit Österreich Forschungs- und Planungs GmbH, Sogeti. Busch, Martin and Grabenhofer-Efferth, Alexander and Wiegl, Marion and Wirl, Charlotte (2013) Report on the current state of play of the 2003 Council Recommendation on the prevention and reduction of health-related harm, associated with drug dependence, in the EU and candidate countries. Vienna: European Commission.

The Rotunda Hospital. (2012) Clinical report 2011. Dublin: The Rotunda Hospital.

National Immunisation Advisory Committee of the Royal College of Physicians of Ireland. (2011) Immunisation guidelines for Ireland, 2008 edition. Online only update September 2011. Dublin: Royal College of Physicians of Ireland.

European Centre for Disease Prevention and Control. (2010) Surveillance and prevention of hepatitis B and C in Europe. Stockholm: ECDC.

European Centre for Disease Prevention and Control. (2010) Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Stockholm: ECDC.

Cox, Gemma and Robinson, Janet (2008) Needle exchange provision in Ireland: The context, current levels of service provision and recommendations. A joint report by the National Drugs Strategy Team and the National Advisory Committee on Drugs. Dublin: National Advisory Committee on Drugs.

European Commission. (2001) European network on HIV/AIDS and hepatitis prevention in prisons. Luxembourg: Office for Official Publications of the European Communities.

Trinity College Dublin. Department of Community Health and General Practice. Long, Jean and Allwright, Shane and Barry, Joseph and Reaper-Reynolds, Sheilagh and Thornton, Lelia and Bradley, Fiona (2000) Hepatitis B, hepatitis C and HIV in Irish prisoners, part II: prevalence and risk in committal prisoners 1999. Dublin: Stationery Office.

Eastern Health Board. Thornton, Lelia and O'Sullivan, Patrick and Barry, Joseph and Fitzgerald, Martin and Hickey, Lorraine and O'Connor, Aideen and Scully, Mary (2000) Hepatitis B infection: surveillance and control in the Eastern Health Board, from policy to practice. Dublin: Eastern Health Board.

Allwright, Shane and Barry, Joseph and Bradley, Fiona and Long, Jean and Thornton, Lelia (1999) Hepatitis B, Hepatitis C and HIV in Irish prisoners: prevalence and risk. Dublin: Stationery Office.

Evidence resource

Public Health England. (2017) Non-fatal overdose among people who inject drugs in England: 2017 report. London: Public Health England. Health Protection Report, 11 (39) 8 p.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Systematic review on active case finding of communicable diseases in prison settings. Stockholm: ECDC. 50 p.

National Institute for Health and Care Excellence. (2017) Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B in children, young people and adults. London: NICE.

Duffell, EF and Hedrich, Dagmar and Mardh, O and Mozalevskis, A [Eurosurveillance] . (2017) Towards elimination of hepatitis B and C in European Union and European economic area countries: monitoring the world health organization’s global health sector strategy core indicators and scaling up key interventions. European Centre for Disease Prevention and Control. Eurosurveillance, 22 (9) 30476. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.9.30476

Stone, Katie, ed. (2016) Global state of harm reduction 2016. London: Harm Reduction International. 148 p.

Public Health England. (2016) Shooting up: infections among people who injected drugs in the UK, 2015. An update: November 2016.. London: Public Health England. 25 p.

European Centre for Disease Prevention and Control. [ECDC] (2016) Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC. 133 p.

Degenhardt, Louisa and Charlson, Fiona and Stanaway, Jeff and Larney, Sarah and Alexander, Lily T and Hickman, Matthew and Cowie, Benjamin and Hall, Wayne and Strang, John and Whiteford, Harvey and Vos, Theo . (2016) Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Elsevier. The Lancet, 16 (12) DOI: http://dx.doi.org/10.1016/S1473-3099(16)30325-5

World Health Organization. (2015) Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization. 166 p.

Stone, Katie, ed. [Harm Reduction International] (2015) Global state of harm reduction 2014. London: Harm Reduction International. 130 p.

Public Health England. (2014) UK: Liver disease profiles. London: Public Health England.

Public Health England. (2014) People who inject drugs: infection risks, guidance and data. London: Public Health England.

Local Government Association, Public Health England. (2013) Hepatitis: Frequently asked questions. London: Local Government Association. 8 p.

Scientific Advisory Committee of the Health Protection Surveillance Centre. [Health Protection Surveillance Centre] (2012) Guidelines for the emergency management of injuries (including needlestick and sharps injuries, sexual exposure and human bites) where there is a risk of transmission of bloodborne viruses and other infectious diseases. Dublin: Health Protection Surveillance Centre and Health Service Executive. 108 p.

World Health Organization. [WHO] (2012) Guidance on prevention of viral hepatitis B and C among people who inject drugs. Geneva: World Health Organization. 4 p. WHO/HIV/2012.18

National Institute for Health and Clinical Excellence. [NICE] (2012) Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection. London: NICE. 76 p.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Hepatitis and drug use.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Prevention and control of infectious diseases among people who inject drugs. Stockholm: European Centre for Disease Prevention and Control. 55 p.

World Health Organization Regional Office for Europe. [WHO] (2011) Management of hepatitis B and HIV coinfection. Clinical protocol for the WHO European Region (2011 revision). Geneva: World Health Organization. 31 p. Protocol 7

Coffey, Emer and Young, David [Royal College of General Practitioners, UK] . (2004) Guidance for hepatitis A and B vaccination of drug users in primary care and criteria for audit. London: Royal College of General Practioners. 8 p.

Dail Debates

[Oireachtas] 270. Mr. Cuffe asked the Minister for Justice, Equality and Law Reform the status of each of the recommendations contained in the 1999 report, Hepatitis B, Hepatitis C and HIV in Irish Prisoners: Prevalence and Risk, commissioned by his Department; if each recommendation has been implemented; if so, the prisons concerned; if not, the reason therefor; and the projected date of implementation of each of the outstanding recommendations. [14684/05]. (05 May 2005)

Newsletter

Substance Misuse Management in General Practice. (2011) Network no. 33. Liver special edition. . London: SMMGP.

Conference or Workshop Item

Kelly, Michael G and Shattock, Alan G (1982) Non-A, Non-B hepatitis and delta infection in Dublin: a preliminary report. In: International Hepatitis Workshop, Edinburgh.

Thesis

O'Sullivan, Patrick (2004) A study of the prevalence of blood-borne viral diseases in injecting drug users receiving methadone maintenance in the National Drug Treatment Centre at Trinity Court in Dublin. Other thesis, The Royal College of Physicians of Ireland.

Long, Jean (2002) Hepatitis B, hepatitis C and HIV in the Irish prisoner population: an overview of prevalence rates and risk factors. PhD thesis, Trinity College Dublin.

Reaper-Reynolds, Sheilagh (1999) Human immunodeficiency virus, hepatitis B and hepatitis C: prevalence and risk factors among committal prisoners in Ireland? MSc thesis, Trinity College Dublin.

FactSheet

Health Protection Surveillance Centre. (2017) Hepatitis B and you. What you need to know when you are newly diagnosed. Dublin: Health Protection Surveillance Centre.

World Health Organization. (2015) Hepatitis B factsheet. Geneva: World Health Organization.

This list was generated on Sun Apr 22 03:18:42 2018 GMT.